Michel Zelaquett/LinkedIn
Apr 23, 2026, 07:33
Michel Zelaquett: Ultra-Minimally Invasive Treatment for Uterine Fibroids
Michel Zelaquett, Founder and Director at Centro de Mioma, shared a post on LinkedIn:
“Ultra-Minimally Invasive Treatment for Uterine Fibroids
No incisions. No scars. Minimal invasion, maximum precision.
Cutting-edge technology in service of uterine preservation and fertility — because every woman deserves access to treatments that respect her body and her future.
Proud to be part of a dedicated team pushing the boundaries of modern gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 15, 2026, 15:57Early Bird Registration Opens for RCOG Female Reproductive Physiology Course – RCOG
-
Jul 15, 2026, 15:53ACOG Joins Coalition to Advance National Women’s Health Strategy – ACOG
-
Jul 15, 2026, 15:44From the Shadow of Pregnancy Loss to a New Pregnancy – RBMO
-
Jul 15, 2026, 15:27Supporting the Launch of the National Strategy to Close the Women’s Health Gap – ASRM
-
Jul 15, 2026, 15:21Sergio Haimovich: AI Is Already Reshaping Scientific Publishing and Disclosure Is Lagging Behind
-
Jul 15, 2026, 15:12The Egg’s Engine Is Fed Plenty of Fuel, It Just Can’t Burn It – Fertility Plus
-
Jul 15, 2026, 15:07Join the Ultrasound in Obstetrics and Gynecology Team as the UOG Social Media Editor – ISUOG
-
Jul 15, 2026, 14:56Can Ultrasound Reliably Detect Residual Cervical Cancer After Conization? – IJGC
-
Jul 15, 2026, 14:27Marco Zaccaria: A Great Webinar, Hosted By BSGE and BMUS